CYP2A13 Antibody (C-term) Blocking Peptide

Artikelnummer: ABT-BP8649B
Artikelname: CYP2A13 Antibody (C-term) Blocking Peptide
Artikelnummer: ABT-BP8649B
Hersteller Artikelnummer: BP8649b
Alternativnummer: ABT-BP8649B-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: Cytochrome P450 2A13, CYPIIA13, CYP2A13
CYP2A13 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco.
NCBI: 1553
UniProt: Q16696
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8649b was selected from the C-term region of human CYP2A13. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.